Stock 000513 LIVZON PHARMACEUTICAL GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
39.41 CNY +1.10% Intraday chart for Livzon Pharmaceutical Group Inc. +5.04% +12.57%
Apr. 26 Livzon Pharmaceutical Factory Receives Approval for the U.S. FDA Approval for the Company's Drug Cetrorelix Acetate for Injection CI
Apr. 24 Livzon Pharmaceutical's Q1 Profit Jumps 4.5%; Revenue Slips 5% MT

Evolution of the average Target Price on Livzon Pharmaceutical Group Inc.

Price target over the last 5 years

History of analyst recommendation changes

11c978fc18586af53e33f97cd3f12265.Px80_VYw6byth6C4CcCgHHoe32aglZPG45TBmDUgbyg.ZnwAjD9di8zu6OjAYYXSaDNE7h-Z86qzi_n2-gV4KH9-WwaPJXuF3_XymA~84bf11ce87af7d7efd6bf263c218e4cd

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
39.41 CNY
Average target price
41.14 CNY
Spread / Average Target
+4.39%
High Price Target
47.5 CNY
Spread / Highest target
+20.53%
Low Price Target
31.43 CNY
Spread / Lowest Target
-20.25%

Consensus detail

Consensus revision (last 18 months)

Ratings for Livzon Pharmaceutical Group Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 000513 Stock
  4. Consensus Livzon Pharmaceutical Group Inc.